+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Next Generation Sequencing Market to 2025 - Regional Analysis and Forecasts by Product; Service; Application; End User, and Country

  • ID: 4801442
  • Report
  • Region: Europe
  • 123 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • Eurofins Scientific
  • F.Hoffman-La Roche Ltd.
  • Illumina, Inc.
  • Macrogen Inc.
  • PerkinElmer, Inc.
  • MORE
The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

The growth of the next generation sequencing market is primarily attributed to the technological advancements in sequencing and an extensive use of genomics for medical applications. However, nonexistence of skilled professionals and high risks associated with genetic data. On the other hand, an extensive use of genomics for medical applications is likely to have a positive impact on the growth of the Europe next generation sequencing market in the coming years.

The genomics is comprised of various technologies such next generation sequencing (NGS), genome editing, gene synthesis and more. These technologies have been utilized for achieving various discoveries for the betterment of the health conditions across the living organisms. The next generation sequencing is widely used in the field of the medical to understand the genetic composition of the patients. The use of NGS has been utilized for the alteration of plants and animals for the desired physical and genetic changes. The technology is used to produce biomarkers. The biomarkers are widely used in clinical research and clinical practice. NGS is among the important developments in genomic technologies, the technology is used for the discovery of oncogenic biomarker and diagnostics. NGS enables in discovery of biomarker and identifying the genetic diseases. In addition, the NGS is used for the developing precision medicine for individual’s genomic information to offer targeted treatment to the individual. NGS have capability of sequencing large sections of a person's genome in very short period of time and can also aid in formulation of precision medicine. Next generation sequencing technology is among the major driver of precision medicine and has improved its accuracy, speed, and cost. Developments in whole genome sequencing has enabled the identification of genes required in the large number of diseases, and biomarkers that indicate disease severity to treatment are gradually being characterized. Therefore, the use of the NGS for the discovery of biomarker have benefited for the early diagnosis and differentiating in disease types. Likewise, precision medicine enables in treatment of the diseases NGS plays significant role for both the application by creating an array of opportunities in future.

In 2017, the consumables segment held a largest market share of 64.0% of the next generation sequencing market, by product. The segment is growing due to the consumables offered by various companies are widely accepted by the consumers and it provides accuracy and precision in the preparation of the NGS. Furthermore, the similar segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

In 2017, the resequencing segment held a largest market share of 66.0% of the next generation sequencing market, by technology. This segment is also expected to dominate the market in 2025 as the rising funding by various government bodies and usage of NGS in the resequencing and targeted sequencing. Furthermore, the genome sequencing segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

Diagnostics segment is anticipated to grow at a CAGR of 22.0% during the forecast period owing to the growth of the technological advancements such as sequencing machines in the developed and developing regions. Moreover, the similar segment held the largest market share of 34.0% for the application segment in the next generation sequencing market and is likely to dominate the market in coming forecast period.

In 2017, the academic & research institutes segment held a largest market share of 45.2% of the next generation sequencing market, by end user. This segment is also expected to dominate the market in 2025. Moreover, the similar segment is anticipated to witness the fastest growth rate of 21.9% during the forecast period, 2017 to 2025. This higher growth rate of the segment owing to the providing the references for further researches are likely to propel the growth of the research centers segment in the coming future.

Some of the major primary and secondary sources for next generation sequencing included in the report are, Non-Invasive Prenatal Testing (NIPT), Food and Drug Administration (FDA), Developing an European - American NGS Network (DEANN), Foreign Direct Investment (FDI) and among others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • Eurofins Scientific
  • F.Hoffman-La Roche Ltd.
  • Illumina, Inc.
  • Macrogen Inc.
  • PerkinElmer, Inc.
  • MORE
Part 1. Introduction
1.1 Scope Of The Study
1.2 Report Guidance

Part 2. Europe Next Generation Sequencing Market - Key Takeaways

Part 3. Europe Next Generation Sequencing Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Next Generation Sequencing Market - By Product
3.2.2 Europe Next Generation Sequencing Market - By Technology
3.2.3 Europe Next Generation Sequencing Market - By Application
3.2.4 Europe Next Generation Sequencing Market - By End User
3.2.5 Europe Next Generation Sequencing Market - By Country
3.3 Pest Analysis

Part 4. Europe Next Generation Sequencing Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Technological Advancements In Sequencing
4.1.2 Rise In The Advancements For Genome Editing Technologies
4.2 Key Market Restraints
4.2.1 Nonexistence Of Skilled Professionals
4.2.2 High Risks Associated With Genetic Data
4.3 Key Market Opportunities
4.3.1 Extensive Use Of Genomics For Medical Applications
4.4 Future Trends
4.4.1 Adoption Of Real-Time PCR Systems
4.5 Impact Analysis

Part 5. Next Generation Sequencing Market - Europe Analysis
5.1 Europe Next Generation Sequencing Market Revenue Forecasts And Analysis
5.2 Market Positioning/ Market Share
5.3 Performance Of Key Players
5.3.1 Illumina, Inc.
5.3.2 Thermo Fisher Scientific, Inc.
5.4 Expert Opinions
5.5 Clinical Trials Analysis
5.5.1 Clinical Trials Analysis
5.5.2 Phase II Clinical Trails
5.5.3 Phase III Clinical Trails
5.5.4 Phase IV Clinical Trails

Part 6. Europe Next Generation Sequencing Market Analysis - By Product
6.1 Overview
6.2 Europe Next Generation Sequencing Market, By Product, 2017 & 2025 (%)
6.3 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Product (US$ Mn)
6.3.1 Europe Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
6.3.1.1 Europe Sample Preparation Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
6.3.2 Europe Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
6.3.2.1 Europe Sequencing Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
6.3.2.2 Europe Data Management & Analysis Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
6.3.3 Europe Platforms Market Revenue And Forecasts To 2025, By Type (US$ Mn)
6.4 Consumables Market
6.4.1 Overview
6.4.2 Europe Consumables Market Revenue And Forecasts To 2025 (US$ Mn)
6.4.3 Sample Preparation Consumables Market
6.4.3.1 Overview
6.4.3.2 Europe Sample Preparation Consumables Market Revenue And Forecasts To 2025 (US$ Mn)
6.4.3.3 DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits & Reagents Market
6.4.3.3.1 Overview
6.4.3.3.2 Europe DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits & Reagents Market Revenue And Forecasts To 2025 (US$ Mn)
6.4.3.4 Library Preparation & Target Enrichment Kits & Reagents Market
6.4.3.4.1 Overview
6.4.3.4.2 Europe Library Preparation & Target Enrichment Kits & Reagents Market Revenue And Forecasts To 2025 (US$ Mn)
6.4.3.5 Quality Control Kits & Reagents Market
6.4.3.5.1 Overview
6.4.3.5.2 Europe Quality Control Kits & Reagents Market Revenue And Forecasts To 2025 (US$ Mn)
6.4.4 Other NGS Consumables Market
6.4.4.1 Overview
6.4.4.2 Europe Other NGS Consumables Market Revenue And Forecasts To 2025 (US$ Mn)
6.5 Services Market
6.5.1 Overview
6.5.2 Europe Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3 Sequencing Services Market
6.5.3.1 Overview
6.5.3.2 Europe Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3.3 Targeted Sequencing Services Market
6.5.3.3.1 Overview
6.5.3.3.2 Europe Targeted Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3.4 RNA Sequencing Services Market
6.5.3.4.1 Overview
6.5.3.4.2 Europe Rna Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3.5 Whole Exome Sequencing Services Market
6.5.3.5.1 Overview
6.5.3.5.2 Europe Whole Exome Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3.6 Chip Sequencing Services Market
6.5.3.6.1 Overview
6.5.3.6.2 Europe Chip Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3.7 Whole Genome Sequencing Services Market
6.5.3.7.1 Overview
6.5.3.7.2 Europe Whole Genome Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.3.8 Other Sequencing Services Market
6.5.3.8.1 Overview
6.5.3.8.2 Europe Other Sequencing Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.4 Data Management & Analysis Services Market
6.5.4.1 Overview
6.5.4.2 Europe Data Management & Analysis Services Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.4.3 NGS Data Analysis Software & Workbenches Market
6.5.4.3.1 Overview
6.5.4.3.2 Europe NGS Data Analysis Software & Workbenches Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.4.4 NGS Data Analysis Market
6.5.4.4.1 Overview
6.5.4.4.2 Europe NGS Data Analysis Market Revenue And Forecasts To 2025 (US$ Mn)
6.5.4.5 Other Data Management & Analysis Services Market
6.5.4.5.1 Overview
6.5.4.5.2 Europe Other Data Management & Analysis Services Market Revenue And Forecasts To 2025 (US$ Mn)

Part 7. Europe Next Generation Sequencing Market Analysis - By Technology
7.1 Overview
7.2 Europe Next Generation Sequencing Market, By Technology, 2017 & 2025 (%)
7.3 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Technology (US$ Mn)
7.3.1 Europe Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025, By Type (US$ Mn)
7.4 Genome Sequencing Market
7.4.1 Overview
7.4.2 Europe Genome Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
7.5 Exome Sequencing Market
7.5.1 Overview
7.5.2 Europe Exome Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
7.6 Resequencing & Targeted Sequencing Market
7.6.1 Overview
7.6.2 Europe Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
7.6.3 Dna-Based Resequencing & Targeted Sequencing Market
7.6.3.1 Overview
7.6.3.2 Europe Dna-Based Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
7.6.4 Rna-Based Resequencing & Targeted Sequencing Market
7.6.4.1 Overview
7.6.4.2 Europe Rna-Based Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
7.7 Other Sequencing Technologies Market
7.7.1 Overview
7.7.2 Europe Other Sequencing Technologies Market Revenue And Forecasts To 2025 (US$ Mn)

Part 8. Europe Next Generation Sequencing Market Analysis - By Application
8.1 Overview
8.2 Europe Next Generation Sequencing Market, By Application, 2017 & 2025 (%)
8.3 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Application (US$ Mn)
8.4 Diagnostics Market
8.4.1 Overview
8.4.2 Europe Diagnostics Market Revenue And Forecasts To 2025 (US$ Mn)
8.5 Drug Discovery Market
8.5.1 Overview
8.5.2 Europe Drug Discovery Market Revenue And Forecasts To 2025 (US$ Mn)
8.6 Precision Medicine Market
8.6.1 Overview
8.6.2 Europe Precision Medicine Market Revenue And Forecasts To 2025 (US$ Mn)
8.7 Others Market
8.7.1 Overview
8.7.2 Europe Others Market Revenue And Forecasts To 2025 (US$ Mn)

Part 9. Europe Next Generation Sequencing Market Analysis - By End USer
9.1 Overview
9.2 Europe Next Generation Sequencing Market, By End USer, 2017 & 2025 (%)
9.3 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By End USer (US$ Mn)
9.4 Academic & Research Institutes Market
9.4.1 Overview
9.4.2 Europe Academic & Research Institutes Market Revenue And Forecasts To 2025 (US$ Mn)
9.5 Hospitals & Clinics Market
9.5.1 Overview
9.5.2 Europe Hospitals & Clinics Market Revenue And Forecasts To 2025 (US$ Mn)
9.6 Pharmaceutical & Biotechnology Companies Market
9.6.1 Overview
9.6.2 Europe Pharmaceutical & Biotechnology Companies Market Revenue And Forecasts To 2025 (US$ Mn)
9.7 Others Market
9.7.1 Overview
9.7.2 Europe Others Market Revenue And Forecasts To 2025 (US$ Mn)

Part 10. Europe Next Generation Sequencing Market Revenue And Forecasts To 2025
10.1 Overview
10.2 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
10.3 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Product (US$ Mn)
10.3.1 Europe Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.3.1.1 Europe Sample Preparation Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.3.2 Europe Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.3.2.1 Europe Sequencing Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.3.2.2 Europe Data Management & Analysis Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.3.3 Europe Platforms Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.4 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Technology (US$ Mn)
10.4.1 Europe Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.5 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Application (US$ Mn)
10.6 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By End USer (US$ Mn)
10.7 Europe Next Generation Sequencing Market Revenue And Forecasts To 2025, By Country (%)
10.8 UK Next Generation Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
10.8.1 UK Next Generation Sequencing Market Revenue And Forecasts To 2025, By Product (US$ Mn)
10.8.1.1 UK Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.1.1.1 UK Sample Preparation Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.1.2 UK Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.1.2.1 UK Sequencing Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.1.2.2 UK Data Management & Analysis Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.1.3 UK Platform Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.2 UK Next Generation Sequencing Market Revenue And Forecasts To 2025, By Technology (US$ Mn)
10.8.2.1 UK Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.8.3 UK Next Generation Sequencing Market Revenue And Forecasts To 2025, By Application (US$ Mn)
10.8.4 UK Next Generation Sequencing Market Revenue And Forecasts To 2025, By End USer (US$ Mn)
10.9 Germany Next Generation Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
10.9.1 Germany Next Generation Sequencing Market Revenue And Forecasts To 2025, By Product (US$ Mn)
10.9.1.1 Germany Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.1.1.1 Germany Sample Preparation Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.1.2 Germany Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.1.2.1 Germany Sequencing Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.1.2.2 Germany Data Management & Analysis Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.1.3 Germany Platform Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.2 Germany Next Generation Sequencing Market Revenue And Forecasts To 2025, By Technology (US$ Mn)
10.9.2.1 Germany Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.9.3 Germany Next Generation Sequencing Market Revenue And Forecasts To 2025, By Application (US$ Mn)
10.9.4 Germany Next Generation Sequencing Market Revenue And Forecasts To 2025, By End USer (US$ Mn)
10.10 France Next Generation Sequencing Market Revenue And Forecasts To 2025 (US$ Mn)
10.10.1 France Next Generation Sequencing Market Revenue And Forecasts To 2025, By Product (US$ Mn)
10.10.1.1 France Consumables Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.1.1.1 France Sample Preparation Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.1.2 France Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.1.2.1 France Sequencing Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.1.2.2 France Data Management & Analysis Services Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.1.3 France Platform Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.2 France Next Generation Sequencing Market Revenue And Forecasts To 2025, By Technology (US$ Mn)
10.10.2.1 France Resequencing & Targeted Sequencing Market Revenue And Forecasts To 2025, By Type (US$ Mn)
10.10.3 France Next Generation Sequencing Market Revenue And Forecasts To 2025, By Application (US$ Mn)
10.10.4 France Next Generation Sequencing Market Revenue And Forecasts To 2025, By End USer (US$ Mn)

Part 11. Next Generation Sequencing Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies In The Next Generation Sequencing Market, 2016-2018
11.3 Organic Growth Strategies
11.3.1 Overview
11.3.2 Organic Growth Strategies In The Next Generation Sequencing Market, 2016-2018
11.3.2.1 Product Launches
11.3.2.1.1 Recent Product Launches By Players In The Ngs Market
11.3.2.2 Product Approval & Enhancements
11.3.2.2.1 Recent Product Approvals And Enhancements By Players In The Ngs Market
11.3.2.3 Expansion
11.3.2.3.1 Recent Expansions By Players In The Ngs Market
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.4.2 Inorganic Growth Strategies In The Next Generation Sequencing Market, 2016-2018
11.4.2.1 Parnerships
11.4.2.1.1 Recent Parnerships Between Players In The Ngs Market
11.4.2.2 Acquisitions
11.4.2.2.1 Recent Acquisitions In The Ngs Market
11.4.2.3 Collaborations
11.4.2.3.1 Recent Collaborations In The Ngs Market
11.4.2.4 Others
11.4.2.4.1 Recent Other Strategies In The Ngs Market

Part 12. Next Generation Sequencing Market -Key Company Profiles
12.1 Illumina, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 Swot Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 Swot Analysis
12.2.6 Key Developments
12.3 Qiagen N.V.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 Swot Analysis
12.3.6 Key Developments
12.4 Beijing Genomics Institute
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product & Services Portfolio
12.4.5 Swot Analysis
12.4.6 Key Developments
12.5 Perkinelmer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 Swot Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 Swot Analysis
12.6.6 Key Developments
12.7 Agilent Technologies
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 Swot Analysis
12.7.6 Key Developments
12.8 Eurofins Scientific
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Services Portfolio
12.8.5 Swot Analysis
12.8.6 Key Developments
12.9 Oxford Nanopore Technologies Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product & Services Portfolio
12.9.5 Swot Analysis
12.9.6 Key Developments
12.10 Macrogen, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Services Portfolio
12.10.5 Swot Analysis
12.10.6 Key Developments

Part 13. Appendix
13.1 About the Publisher
13.2 Glossary Of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.,
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
Note: Product cover images may vary from those shown
Adroll
adroll